Intest Res Search

CLOSE


‘Intestinal Research’ (Intest Res) is the joint official publication of the Asian Organization for Crohn's and Colitis (AOCC), Chinese Society of IBD (CSIBD), Japanese Society for IBD (JSIBD), Korean Association for the Study of Intestinal Diseases (KASID), Taiwan Society of IBD (TSIBD) and Colitis Crohn's Foundation (India) (CCF, india).
The aim of the Journal is to provide broad and in-depth analysis of intestinal diseases, especially inflammatory bowel disease, which shows increasing tendency and significance.As a Journal specialized in clinical and translational research in gastroenterology, it encompasses multiple aspects of diseases originated from the small and large intestines.

Review

April 20, 2023


Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions
Harris A. Ahmad, James E. East, Remo Panaccione, et al.
Intest Res. 2023;21(3):283-294.

Review

May 31, 2023


Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer
Chan Hyung Lee, Seong-Joon Koh, Zaher A Radi, et al.
Intest Res. 2023;21(3):295-305.

Review

April 20, 2023


Does caffeine have a double-edged sword role in inflammation and carcinogenesis in the colon?
Emiko Mizoguchi, Takayuki Sadanaga, Toshiyuki Okada, et al.
Intest Res. 2023;21(3):306-317.

Original Article

February 10, 2023


Risk of venous thromboembolism with a central venous catheter in hospitalized Japanese patients with inflammatory bowel disease: a propensity score-matched cohort study
Yasuhiro Aoki, Hiroki Kiyohara, Yohei Mikami, et al.
Intest Res. 2023;21(3):318-327.

Original Article

July 27, 2023


Diagnosis of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
Han Hee Lee, Jae Jun Park, Bo-In Lee, et al.
Intest Res. 2023;21(3):328-338.

Original Article

July 27, 2023


Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
Eun Mi Song, Soo-Young Na, Sung Noh Hong, et al.
Intest Res. 2023;21(3):339-352.

Original Article

July 27, 2023


Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
Yu Kyung Jun, Seong-Joon Koh, Dae Seong Myung, et al.
Intest Res. 2023;21(3):353-362.

Original Article

June 16, 2023


Vaccination in patients with inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
Su Bum Park, Kyeong Ok Kim, Hong Sub Lee, et al.
Intest Res. 2023;21(3):363-374.

Original Article

October 18, 2022


Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD
Arshdeep Singh, Yogesh Kumar Gupta, Ashvin Singh Dhaliwal, et al.
Intest Res. 2023;21(3):375-384.

Original Article

March 17, 2023


Submucosal fat accumulation in Crohn’s disease: evaluation with sonography
Tomás Ripollés, María Jesús Martínez-Pérez, José María Paredes, et al.
Intest Res. 2023;21(3):385-391.

Original Article

December 2, 2022


Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis
Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, et al.
Intest Res. 2023;21(3):392-405.

Use of thiopurines in inflammatory bowel disease: an update
Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, et al.
Intest Res. 2022;20(1):11-30.

Review

Epub April 15, 2021

Intestinal tuberculosis or Crohn’s disease: a review of the diagnostic models designed to differentiate between these two gastrointestinal diseases
Julajak Limsrivilai, Nonthalee Pausawasdi
Intest Res. 2021;19(1):21-32.

Review

Epub April 22, 2020

Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
Sang Hyoung Park
Intest Res. 2022;20(2):159-164.

Review

Epub April 29, 2022

Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis
Shin Ju Oh, Ga Young Shin, Hosim Soh, et al.
Intest Res. 2021;19(3):323-331.

Original Article

Epub August 18, 2020

Patients with celiac disease are at high risk of developing metabolic syndrome and fatty liver
Ashish Agarwal, Alka Singh, Wajiha Mehtab, et al.
Intest Res. 2021;19(1):106-114.

Original Article

Epub April 22, 2020

Management of Clostridioides difficile infection in patients with inflammatory bowel disease
Sahil Khanna
Intest Res. 2021;19(3):265-274.

Review

Epub August 18, 2020

Natural history of inflammatory bowel disease: a comparison between the East and the West
Eun Mi Song, Suk-Kyun Yang
Intest Res. 2022;20(4):418-430.

Review

Epub December 2, 2021

The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis
Yujin Jeong, Seong Ran Jeon, Hyun Gun Kim, et al.
Intest Res. 2021;19(1):62-70.

Original Article

Epub May 8, 2020

Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry
Ajit Sood, Kirandeep Kaur, Ramit Mahajan, et al.
Intest Res. 2021;19(2):206-216.

Original Article

Epub July 13, 2020

Quality of life in inflammatory bowel diseases: it is not all about the bowel
Ronald Keller, Nazar Mazurak, Laura Fantasia, et al.
Intest Res. 2021;19(1):45-52.

Original Article

Epub February 27, 2020

Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study
Choon Jin Ooi, Ida Normiha Hilmi, Hyo-Jong Kim, et al.
Intest Res. 2021;19(1):71-82.

Original Article

Epub September 4, 2020

Management of inflammatory bowel disease in the COVID-19 era
Kyeong Ok Kim, Byung Ik Jang
Intest Res. 2022;20(1):3-10.

Review

Epub February 3, 2021

The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment
Sang Hoon Kim, Yun Jeong Lim
Intest Res. 2022;20(1):31-42.

Review

Epub May 21, 2021

Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study
Yasuo Suzuki, Takashi Hagiwara, Mariko Kobayashi, et al.
Intest Res. 2021;19(3):301-312.

Original Article

Epub August 20, 2020

Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment
Shintaro Akiyama, Victoria Rai, David T. Rubin
Intest Res. 2021;19(1):1-11.

Review

Epub November 5, 2020

Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis
Toshifumi Hibi, Isao Kamae, Philippe Pinton, et al.
Intest Res. 2021;19(1):53-61.

Original Article

Epub April 22, 2020

Yarrow oil ameliorates ulcerative colitis in mice model via regulating the NF-κB and PPAR-γ pathways
Maged E. Mohamed, Sahar A. Elsayed, Hafez R. Madkor, et al.
Intest Res. 2021;19(2):194-205.

Original Article

Epub August 21, 2020

Clinical practice guideline for endoscopic resection of early gastrointestinal cancer
Chan Hyuk Park, Dong-Hoon Yang, Jong Wook Kim, et al.
Intest Res. 2021;19(2):127-157.

Statement

Epub October 13, 2020

Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI)
Tadakazu Hisamatsu, Hyo Jong Kim, Satoshi Motoya, et al.
Intest Res. 2021;19(4):386-397.

Original Article

Epub December 1, 2020

Efficacy and safety of vedolizumab in Crohn’s disease in patients from Asian countries in the GEMINI 2 study
Rupa Banerjee, Sai Wei Chuah, Ida Normiha Hilmi, et al.
Intest Res. 2021;19(1):83-94.

Original Article

Epub December 31, 2020

Temporal trend in the natural history of ulcerative colitis in a country with a low incidence of ulcerative colitis from 2000 through 2018
Satimai Aniwan, Julajak Limsrivilai, Supot Pongprasobchai, et al.
Intest Res. 2021;19(2):186-193.

Original Article

Epub August 18, 2020

An overview of the gut side of the SARS-CoV-2 infection
Bruna Barbosa da Luz, Natalia Mulinari Turin de Oliveira, Isabella Wzorek França dos Santos, et al.
Intest Res. 2021;19(4):379-385.

Review

Epub November 6, 2020

Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, et al.
Intest Res. 2021;19(4):419-429.

Original Article

Epub November 10, 2020

Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
Tadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, et al.
Intest Res. 2021;19(4):408-418.

Original Article

Epub November 20, 2020

Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?
Nor Hamizah Shafiee, Zahara Abdul Manaf, Norfilza M. Mokhtar, et al.
Intest Res. 2021;19(2):171-185.

Review

Epub February 3, 2021

Population pharmacokinetics of vedolizumab in Asian and non-Asian patients with ulcerative colitis and Crohn’s disease
Hiroyuki Okamoto, Nathanael L. Dirks, Maria Rosario, et al.
Intest Res. 2021;19(1):95-105.

Original Article

Epub July 10, 2020

Crohn’s disease at radiological imaging: focus on techniques and intestinal tract
Giuseppe Cicero, Silvio Mazziotti
Intest Res. 2021;19(4):365-378.

Review

Epub November 25, 2020

Gut microbiome and checkpoint inhibitor colitis
Kanika Sehgal, Sahil Khanna
Intest Res. 2021;19(4):360-364.

Review

Epub December 1, 2020

Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis
Anupam K. Singh, Anuraag Jena, Praveen Kumar-M, et al.
Intest Res. 2022;20(1):134-143.

Original Article

Epub January 18, 2021

Trends of inflammatory bowel disease at a tertiary care center in northern India
Ajit Sood, Kirandeep Kaur, Arshdeep Singh, et al.
Intest Res. 2021;19(3):282-290.

Original Article

Epub August 18, 2020

  • Journal Impact Factor 4.9
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD

ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2023 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next
Close layer
prev next